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ABSTRACT  
Background: Incidence of psychomotor and psychiatric i l lness has promoted an 
awareness regarding the mental and emotional well -being as an important 
criterion of health.  Research on depression is one of the important researches in 
psychiatric medicine.  Negative reactions to l ife's situations become repetitively 
intense and frequent leading to symptoms of depression. Aim: A study on changes 
between antioxidant levels in cases of depression. Method: It was a Case Control 
Observational Study. The patients newly diagnosed by psychiatrist & having 
depression were assessed with Hamilton's depression scale are included in the 
study. The controls were free from depression. The blood sample was collected 
from each case and control at fasting. Serum Malondialdehyde (MDA), Serum 
Tocopherol (Vitamin-E) Serum Ascorbic acid (Vitamin-C) levels were estimated. 
Result: Category I: Group I, II, III MDA levels were 2.02±0.16, 2.02±0.16, 2.02±0.15 
respectively. In Category II: Group I, II, III MDA levels were 6.28±0.77, 5.31±1.33, 
5.74±1.13 respectively. Category I : Group I, II, III Vit E levels were 11.27 ± 1.21, 
10.99 ± 1.03, 11.44 ± 1.20respectively.  In Category II: Group I, II, III Vit E levels 
were 9.92 ± 1.14, 10.44 ± 1.35, 10.21 ± 1.30respectively.  Category I: Group I, II, III 
Vit C levels were 0.87 ± 0.06, 0.89 ± 0.14, 0.89 ± 0.06respectively. In Category II: 
Group I, II, III Vit C levels were 0.82±0.01, 0.82±0.01, 0.82±0.01 respectively. 
Conclusion: There is a significant difference between mean values of height & 
weight in Category I  and Category II. Thus, the decreased antioxidant levels in 
depression cases show marked “oxidant - antioxidant imbalance” with evidence of 
increased oxidative stress. 
KEYWORDS: Pyschaitric i l lness, Serum Malondialdehyde, Serum Tocopherol, 
Serum ascorbic acid. 
 
INTRODUCTION   
Incidence of psychomotor and psychiatric i l lness has 
promoted an awareness regarding the mental and emotional 
well-being as an important criterion of health.  Research on 
depression is one of the important researches in psychiatric 
medicine.  Negative reactions to l ife's situations become 
repetitively intense and frequent leading to symptoms of 
depression: Depression is very common i.e. seventeen per 
cent of all  people experience depression  [1]. 
Age groups, in almost all  walks of l ife. Children or adults, 
develop depression symptoms. Intense sadness, loss of 
interest or pleasure in normal activities, sleep disturbances or 
oversleeping, change in appetite and decreased energy level; 
feelings of helplessness and thoughts of suicide are sequels to 
stress induced depression. 
Exact mechanism of depression is not known. Depression 
may be due to Genetic Factors  [2], Environmental Factors  [2,3], 
Neurobiological Factors  [4], Depressed person as a parent [3]. 
In addition, there are many environmental factors, such as 
loss of a loved one, unemployment, an unexpected medical 
i l lness, that appear to increase the likelihood of depression [5]. 
The present study was designed to find the association 
between antioxidant enzymes malondialdehyde, Vitamin C 
and Vitamin E in depressive subjects& control . 
Aim: A study on changes between antioxidant levels in cases 
of depression. 
Objectives:  
1. To estimate and compare serum Malondialdehyde, 
ascorbic acid (Vitamin C) & tocopherol (Vitamin E) l evel s  
in patients with mental depressive group and controls   
2. To find out changes between severity of depression & 
antioxidants levels  
3. To estimate severity of depression & levels of 
antioxidants 
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MATERIAL & METHOD  
Study Design: It was a Case Control Observational Study. 
Ethics committee: The study protocol was approved by the 
institutional ethics committee.  
Sample size: The depressed group includes 83 patients 
whereas the 100 normal individuals without any psychiatric 
disorder were taken as controls. 
Sampling method: Non Probability Purposive sampling 
method was adopted for selection of subjects.  
The patients newly diagnosed by psychiatrist & having 
depression were assessed with Hamilton's depression scale 
are included in the study. 
Matching of case and control: Controls were matched with 
depression patients with regard to age.  
Group I consist of – 20-30 years, Group II consist of – 31-40 
years and Group III consist of – 41-55 years. 
Selection of Control group:  
Inclusion criteria: The controls were free from depression, 
age varies from 20 to 55 years, free from clinical morbidities 
other than depression and will ing to participate in the study 
Exclusion criteria: History of consumption of psychotropic 
substance and suffering from hypertension 
Selection of depression cases:  
Inclusion criteria: The depression cases were diagnosed by 
psychiatrist & rated on the basis  of Hamilton’s depression 
scale []. Age group varies from 20-55 years, the cases were 
free from clinical morbidities , will ing to participate in the 
study and able to cooperate in conduction of autonomic 
function test 
Exclusion criteria: History of substance use disorder, suffering 
from hypertension 
Groups: Collection of blood sample: First the written consent 
was obtained from all  subjects. The blood sample was 
collected from each case and control at fasting (in the 
morning to avoid diurnal variation of oxidative stress) from 
cubital vein with all  aseptic precautions . Eight ml blood was 
collected (4ml in plain bulb and 4ml in chemistry bulb) and 
serum was separated by centrifugation at 3000 rpm for 10 
minutes.  
Parameters studied  
1. Serum Malondialdehyde (MDA) 
Method: Buege and Aust [6] 
Normal Value: 2 to 2.5 nmoles /mill i l iter 
Principle:- Malonyldialdehyde (MDA) is highly reactive three 
carbon dialdehyde, produced from lipid hydroperoxidation. I t 
can, however, also be derived from hydrolysis of pentoses, 
deoxyriboses, hexoses, from some amino acids and from 
DNA. MDA estimation was done by thiobarbituric acid 
reaction. MDA is measured as an index of l ipid peroxidation. 
2. Serum Tocopherol (Vitamin-E) 
Method: Baker & Frank [7] 
Normal Value: 5- 18 micrograms/liter 
Principle: Serum tocopherol is measured by its ability to 
cause reduction of ferric to ferrous ions which then form a 
red complex with a adipyridil. Tocopherols and carotenes are 
first extracted into xylene and the absorbance is read at 460 
nm to measure the carotenes. A correction for the carotenes 
is made after adding ferric chloride and reading at 520nm. 
3. Serum Ascorbic acid (Vitamin-C): 
Method: Ayekyaw [8]  
Normal Value: 0.5 to 1.5 mill igram/deciliter 
Principle:- The acid phosphotungustate is  specific and 
sensitive for ascorbic acid determination with good 
reproducibil ity. The acid phosphotungstate used, serves not 
only as protein precipitant and ascorbic acid extractant but 
also as color reagent. 
Data analysis: The data analysis was done by descriptive 
statistics as mean, SD, Percentage.  
 
RESULTS 
Table 1.  Comparison of mean values of Anthropometric Parameters in Category I and Category II  
Anthropometric 
Parameter  
Category I       
(n =100) 
Range Category II (n =83) 
Mean ± SD 
Range 
 
‘p’ value  
 
Age(Yrs) 
Group I (26) 26.35 ± 2.53 22 – 30 Group I (11) 26.45 ± 2.68 21-30 p < 0.05 
Group II (38) 35.75 ± 2.80 31 – 40 Group II (39) 36.03 ± 3.10 31-40 p < 0.05 
Group III (36) 46.72 ± 4.14 41 – 55 Group III (33) 46.91 ± 3.48 41-55 p < 0.05 
Height (cms) 
Group I (26) 154.35 ± 4.60 146 – 163 Group I (11) 155.55 ± 8.37 132-164 p<0.05* 
Group II (38) 156.71 ± 4.83 147 – 165 Group II (39) 152.54 ± 6.90 136-165 p<0.05* 
Group III (36) 155.33 ± 5.30 132 – 164 Group III (33) 152.42 ± 7.33 132-164 p<0.05* 
Weight (cms) 
Group I (26) 51.98 ± 8.55 40 – 75 Group I (11) 51.00 ± 7.33 42-64 p<0.05* 
Group II (38) 54.11 ± 8.52 40 – 76 Group II (39) 50.62 ± 6.31 40-64 p<0.05* 
Group III (36) 53.83 ± 7.47 40 - 64 Group III (33) 48.15 ± 6.10 40-64 p<0.05* 
*Significant. The comparison of all variables under study was done by Students unpaired “t” test at 5% level of significance.  
At the end of the study the results of the severity score, parameters and the level of antioxidants and autonomic function tests 
of each individual will be compared by an analysis of the variability in repeated measures. 
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Table 2. Comparison of mean values of Antioxidants in category I and Category II 
ATIOXIDANTS Category I      
(n  =100) 
Range 
 
Category II                 
                  (n =83) 
 Mean ± SD 
Range 
 
‘p’ value 
  
Mean ± SD  
MDA nmol/ml 
Group I (26) 2.02 ± 0.16 1.84 - 2.45 Group I (11) 6.28 ± 0.77 5.01 - 7.12 p <0.05* 
Group II (38) 2.01 ± 0.16 1.84 - 2.45 Group II (39) 5.31 ± 1.33 3.11 - 7.23 p <0.05*  
Group III (36) 2.02 ± 0.15 4.0 - 7.23 Group III (33) 5.74 ± 1.13 4.0 -7.23 p <0.05* 
Vit E mg/l 
Group I (26) 11.27 ± 1.21 10.55 - 9.9 Group I (11) 9.92 ± 1.14 10.4 - 9.45 p <0.05* 
Group II (38) 10.99 ± 1.03 10.55 - 9.9 Group II (39) 10.44 ± 1.35 10.25 - 9.45 p <0.05*  
Group III (36) 11.44 ± 1.20 10.25 - 9.45 Group III (33) 10.21 ± 1.30 10.2 - 9.45 p <0.05* 
Vit C mg/dl 
Group I (26) 0.87 ± 0.06 0.8 - 1.00 Group I (11) 0.82 ± 0.01 0.81 - 0.84 p <0.05* 
Group II (38) 0.89 ± 0.14 0.1-  0.99 Group II (39) 0.82 ± 0.01 0.81 - 0.84 p <0.05*  
Group III (36) 0.89 ± 0.06 0.81 - 0.84 Group III (33) 0.82 ± 0.01 0.81 - 0.84 p <0.05* 
          *Significant  
DISCUSSION  
Many brain chemicals ("neurochemicals") and hormones have 
been linked to the development of depression (e.g., 
norepinephrine, dopamine, thyroid hormones) [9]. However, 
research studies have implicated disturbances in the 
serotonin (5-HT) system and the Limbic Hypothalamic-
Pituitary-Adrenal (LHPA) axis as two of the neurobiological 
alterations most consistently associated with mood-altering 
i l lness [10,11,12,13]. Recent works, in fact, has strongly sugges ted 
that the interaction between these two biochemical systems 
may play a significant role.Changes in brain chemic a ls oc c ur  
which have also found in suicide victims with a history of 
depression [11]. This suggests that a chronic or severe stress 
(e.g., loss of a spouse, serious i l lness or injury, history of 
abuse) may cause similar neurochemical changes in 
vulnerable people, therefore triggering episodes of 
depression[9]. Studies of depressed patients suggest that 
decreased levels of serotonin in brain are associated with 
decreased mood, while increased levels of serotonin are 
associated with increased levels of mood [14].  
Antioxidants are substances that act as shields or barr i ers to 
prevent the invading free radicals from doing harm to cells  
[9]. Antioxidants are as they give up their own electrons to 
free radicals. When free radical gains the electron from an 
antioxidant it no longer needs to attack the cell  and the chain 
reaction of oxidation is broken. After donating an electron a n 
antioxidant becomes a free radical  [9]. Antioxidants in this 
state are not harmful as they have the ability to 
accommodate the change in electrons without becoming 
reactive. 
The human body has an elaborate antioxidant defense 
system. Antioxidants are manufactured within the body and 
can also be extracted from the food items such as fruits, 
vegetables, seeds, nuts, meats and oil. There are two lines of 
antioxidant defense within the cell. The first l ine, found in the 
fat soluble cellular membrane consists of vitamin E, Beta 
carotene and coenzyme Q. Inside the cell  water soluble 
antioxidant scavengers are present. These include Vit C, 
glutathione peroxidase, superoxide dismutase and catalase 
[14]. 
CONCLUSION  
There is a significant difference between mean values of 
height & weight in Category I and Category II. Thus the 
decreased antioxidant levels in depression cases show 
marked “oxidant - antioxidant imbalance” with evidence of 
increased oxidative stress. The cause effect relationship of 
decrease in antioxidant capacity in subjects with depression 
needs further study. 
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